Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling

Doxorubicin (DOX) is a wide-spectrum antitumor agent, but its clinical application is largely limited by its cardiotoxicity. Therefore, identification of effective agents against DOX-induced cardiotoxicity is of critical importance. The present study aimed to determine the beneficial role of punical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Mingfang, Zhang, Linlin, Yan, Yuanming, Lin, Huizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522706/
https://www.ncbi.nlm.nih.gov/pubmed/31015369
http://dx.doi.org/10.1042/BSR20190229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522706/
https://www.ncbi.nlm.nih.gov/pubmed/31015369
http://dx.doi.org/10.1042/BSR20190229

Ejemplares similares